News

Allegion's Upcoming Earnings: What Investors Should Know

Allegion's Upcoming Earnings: What Investors Should Know

Understanding Allegion's Earnings Expectations

Allegion (NYSE: ALLE) is preparing to unveil its quarterly earnings report soon, and investors are eager to get insights into the company's performance. This report promises to offer key indicators that may help shape Allegion's future trajectory in the market.

Analysts are predicting that Allegion will achieve an earnings per share (EPS) of around $1.98. Investors are looking for positive news not only on whether the company meets or exceeds this estimate but also for optimistic guidance pertaining to future growth.

It’s important for new investors to understand that sometimes it’s not merely a case of beating earnings estimates that moves stock prices, but also the guidance provided for subsequent quarters.

Reviewing Past Earnings Performance

In the last quarter, Allegion managed to surpass EPS expectations by $0.12, resulting in a noticeable share price uptick of 3.93% the day following the announcement. Let’s take a closer look at Allegion's historical performance and how it compares with past estimates:

Quarterly Performance Summary

In the previous quarters, the company has shown a consistent ability to meet or exceed estimates, contributing to investor confidence. This historical performance demonstrates Allegion’s capacity to maintain competitive growth.

Current Share Price Context

As of a recent date, Allegion's shares were trading at approximately $150.6. This represents a noteworthy increase of 55.08% over the last year, indicating a strong bullish sentiment among long-term investors anticipating upcoming earnings announcements.

Analyst Consensus on Allegion

Gaining insight from market analysts is essential for informed investment decisions. Allegion has garnered a consensus rating categorized as Neutral based on five separate analyst ratings, with an average 12-month price target of $138.2. This price target suggests a potential downside of about 8.23% from current levels.

Comparative Analysis with Industry Peers

In understanding Allegion's market positioning, it’s beneficial to compare it with peers such as Advanced Drainage Systems, A.O. Smith, and Fortune Brands. This comparison reveals the broader context within the industry.

  • Advanced Drainage Systems is projected to outperform with an anticipated price target of $188.25, suggesting a potential upside of 25.0%.
  • Analysts have categorized A.O. Smith as Neutral, suggesting a potential downside of around 44.89% with a price target of $83.0.
  • Fortune Brands holds a Buy rating, implying a potential downside of 39.11% with a target of $91.7.

Peer Performance Insights

In reviewing performance metrics for each company, we can delve into key industry benchmarks that illustrate where Allegion stands:

Consensus Ratings Overview

Allegion holds a middle ground in terms of consensus ratings but leads in revenue growth among its competitors. However, it lags in gross profit and return on equity metrics.

Discovering Allegion: Company Background

Allegion is a notable global security company, offering a suite of reputable brands, including Schlage, Von Duprin, and LCN. Formed through a spinoff from Ingersoll-Rand in December 2013, Allegion derives a significant portion of its revenue domestically, serving primarily the U.S. market.

Diving into Allegion's Financial Performance

Market Capitalization Considerations: While Allegion exhibits growth potentials, its market capitalization remains somewhat constrained, reflecting growth expectations and operational capacity.

Revenue Trends: Notably, Allegion has reported a revenue growth rate of approximately 5.82% over the past three months. This growth positions it favorably against industry peers.

Profit Margins: The company's strong financial management is evident from its impressive net margin, which surpasses industry averages at 16.09%.

Return Metrics: Allegion showcases effective equity utilization with a return on equity (ROE) of 11.2%, although its return on assets (ROA) stands lower than competitors at 3.43%, indicating potential areas for improvement.

Leverage Considerations: A high debt-to-equity ratio of 1.69 signals a notable reliance on borrowed funds, which could pose risks in financial stability.

Frequently Asked Questions

What is Allegion expected to report for their EPS?

Analysts estimate an EPS of $1.98 for the upcoming report.

How has Allegion performed in recent quarters?

The company beat EPS estimates by $0.12 last quarter, resulting in a positive stock price reaction.

What is Allegion's current stock price?

As of late October, Allegion's stock was trading at approximately $150.6.

What are analysts saying about Allegion's future?

The consensus rating is Neutral, with a price target suggesting a potential downside.

Who are Allegion's main competitors?

Allegion competes with companies like Advanced Drainage Systems, A.O. Smith, and Fortune Brands.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading

Top 5 Most Recently Viewed Articles

David Newman Honored with Alexander S. Melvin Award for Leadership

Updated Category News Views 245

David Newman Receives the Prestigious Alexander S. Melvin Award David Newman, the principal director of Fiscal Agents Savings and Investments, has been celebrated for his exceptional contributions to the financial services sector. With an impressive career spanning 45 years as a deposit broker, Newman's latest honor is the 2024 Alexander S. Melvin Award for his...

Continue Reading
Investors May Lead Securities Fraud Lawsuit Against VERV

Updated Category News Views 44

Opportunity for Investors in Verve Therapeutics, Inc. If you’re an investor in Verve Therapeutics, Inc. (NASDAQ: VERV), there's an exciting opportunity on the horizon. The Rosen Law Firm, known for its strong reputation in standing up for investor rights, is reaching out to potential plaintiffs who may have purchased securities of Verve Therapeutics within a specific...

Continue Reading
Gundry MD's Award-Winning Olive Oil Recognized for Excellence

Updated Category News Views 228

Gundry MD's Olive Oil Achieves Prestige at Nourish Awards Celebrated for its excellence in the Store Cupboard Essentials category, Gundry MD's Olive Oil delivers extraordinary health benefits. Gundry MD® is a pioneer in wellness solutions founded by the esteemed heart surgeon Dr. Steven Gundry. This innovative brand has gained recognition for its new Polyphenol-Rich...

Continue Reading
Travelers Prepares for Q3 Earnings: Insights and Predictions

Updated Category News Views 92

Travelers Companies, Inc. Anticipates Q3 Earnings Results The Travelers Companies, Inc. (NYSE: TRV) is gearing up for its third-quarter earnings report. With the earnings announcement approaching, it's essential to review the performance indicators and what investors can expect. Investors are keenly interested in how the company performed in relation to last year and the...

Continue Reading
Allegiant Expands Route Network with Affordable Fares Starting at $39

Updated Category News Views 378

Allegiant Expands Its Flight Services Allegiant Travel Company (NASDAQ: ALGT) has recently unveiled an exciting announcement regarding the expansion of its route network. The airline is proud to introduce five new nonstop routes to eight popular destinations throughout the country, catering to travelers looking for affordable and convenient travel options. Affordable...

Continue Reading